One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-148457
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 22 |
Affiliation: Agostino Gemelli University Polyclinic, Charles University, BeiGene (China), North Shore Hospital, Washington University in St. Louis, Dana-Farber Cancer Institute, University of Sydney, Concord Repatriation General Hospital, Frankston Hospital, The Maria Sklodowska-Curie National Research Institute of Oncology, Medical University of Lodz, Karolinska Institutet, Karolinska University Hospital, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Medical University of Lublin, Paracelsus Medical University, Monash Health, Monash University, Ospedale "Santa Maria delle Croci" di Ravenna, University of Washington, Fred Hutch Cancer Center, University of Melbourne, Peter MacCallum Cancer Centre, Royal Melbourne Hospital, St Vincent's Hospital, University Hospital Hradec Králové, Medical University of Silesia, St James's University Hospital, Duke University, Tennessee Oncology, Sarah CannonSEQUOIA: Results of a Phase 3 Randomized Study of Zanubrutinib versus Bendamustine + Rituximab (BR) in Patients with Treatment-Naïve (TN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
